Art

J-GLOBAL ID：201902219970175769   Reference number：19S0467770

Amino acid PET tracers are reliable markers of treatment responses to single-agent or combination therapies including temozolomide, interferon-β, and/or bevacizumab for glioblastoma

Author (9)： Ono, Takahiro (Department of Neurosurgery, Akita University Graduate School of Medicine) ,  Sasajima, Toshio (Department of Neurosurgery, Akita University Graduate School of Medicine) ,  Mizoi, Kazuo (Department of Neurosurgery, Akita University Graduate School of Medicine) ,  Shimizu, Hiroaki (Department of Neurosurgery, Akita University Graduate School of Medicine) ,  Doi, Yoshihiro (Research Center, Nihon Medi-Physics Co. Ltd.) ,  Oka, Shuntaro (Research Center, Nihon Medi-Physics Co. Ltd.) ,  Ono, Masahiro (Research Center, Nihon Medi-Physics Co. Ltd.) ,  Kanagawa, Masaru (Research Center, Nihon Medi-Physics Co. Ltd.) ,  Baden, Atsumi (Research Center, Nihon Medi-Physics Co. Ltd.)
Material： Nuclear Medicine and Biology
Volume： 42  Issue： 7  Page： 598-607  Publication year： 2015 
JST Material Number： SCOPUS  ISSN： 0969-8051  CODEN： NMBIE 
Country of issue： United States (USA)  Language： English (EN)

Terms in the title (3)： PET ,  ARE ,  BEVACIZUMAB